Provided by Tiger Fintech (Singapore) Pte. Ltd.

CITIUS ONCOLOGY INC

0.6600
+0.03906.28%
Post-market: 0.6300-0.0300-4.55%17:26 EDT
Volume:44.43K
Turnover:28.89K
Market Cap:47.22M
PE:-1.98
High:0.6719
Open:0.6307
Low:0.6307
Close:0.6210
Loading ...
Apr 04, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Jan 28, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Major Issues Report

Form 8-K - Current report
Dec 27, 2024

Major Issues Report

Form 8-K - Current report
Dec 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 13, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 17, 2024

Major Issues Report

Form 8-K - Current report
Aug 17, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Aug 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 13, 2024

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]